Form 4 for MRNA Moderna
Accepted 2022-11-25 00:00:00 ET · period of report 2022-11-23 · accession 0001127602-22-026394 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-11-25 | 2022-11-23 | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $176.20 | -40.0K | 5.41M | -0.7% | -$7.05M |
| D | 2022-11-25 | 2022-11-23 | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +40.0K | 5.45M | +0.7% | +$39.6K |
| D | 2022-11-25 | 2022-11-23 | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.00 | -40.0K | 2.47M | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-23 | S | D | 4,094 | $177.00 | 5,414,646 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $176.74 to $177.62. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 2 | Common | Common Stock | 2022-11-23 | S | D | 200 | $179.27 | 5,411,946 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $179.24 to $179.30. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 3 | Common | Common Stock | 2022-11-23 | S | D | 19,799 | $176.23 | 5,418,740 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $175.72 to $176.72. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 4 | Common | Common Stock | 2022-11-23 | S | D | 13,407 | $175.41 | 5,438,539 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $174.71 to $175.71. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 5 | Common | Common Stock | 2022-11-23 | M | A | 40,000 | $0.99 | 5,451,946 | D | — | — | |
| 6 | Common | Common Stock | 2022-11-23 | S | D | 2,500 | $178.60 | 5,412,146 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $177.87 to $178.70. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 7 | Derivative | Stock Option (Right to Buy) | 2022-11-23 | M | D | 40,000 | $0.00 | 2,467,155 | D | $0.99 · — to 2023-08-19 | 40,000 Common Stock | (F9) This option is fully vested and exercisable. |